Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inderal with or without rosuvastatin for migraine attacks
IRCT20120215009014N267Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Apr 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in migraine comparing Inderal + rosuvastatin with Inderal + placebo (2 arms). Primary endpoint: Number of migraine attacks. Started Apr 2019; status: completed.
02
Drugs
propranololrosuvastatin
03
Conditions
migraine
Beyond the preview
Go deeper on IRCT20120215009014N267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N267.